86. Boyce JR, Ness T, Castroman P, Gleysteen JJ: A pre-
liminary study of the optimal anesthesia positio-
ning for the morbidly obese patient. Obes Surg
13:4–9, 2003.
87. Perilli V, Sollazzi L, Bozza P, et al: The effects of the
reverse Trendelenburg position on respiratory
mechanics and blood gases in morbidly obese
patients during bariatric surgery. Anesth Analg 91:
1520–1525, 2000.
88. Ungern-Sternberg BS, Regli A, Schneider MC, et al:
Effect of obesity and site of surgery on perioperative
lung volumes. Br J Anaesth 92:202–207, 2004.
89. Bardoczky GI, Yernault JC, Houben JJ, d’Hollander
AA: Large tidal volume ventilation does not improve
oxygenation in morbidly obese patients during
anesthesia. Anesth Analg 81:385–388, 1995.
90. Pelosi P, Ravagnan I, Giurati G, et al: Positive end-
expiratory pressure improves respiratory function
in obese but not in normal subjects during anesthe-
sia and paralysis. Anesthesiology 91:1221–1231,
1999.
91. El Dawlatly AA, Al Dohayan A, Abdel-Meguid ME,
et al: The effects of pneumoperitoneum on respira-
tory mechanics during general anesthesia for baria-
tric surgery. Obes Surg 14:212–215, 2004.
92. Sprung J, Whalley DG, Falcone T, et al: The effects
of tidal volume and respiratory rate on oxygenation
and respiratory mechanics during laparoscopy in
morbidly obese patients. Anesth Analg 97:268–274,
2003.
93. Whalen FX, Gajic O, Thompson GB, et al: The
effects of the alveolar recruitment maneuver and
positive end-expiratory pressure on arterial oxyge-
nation during laparoscopic bariatric surgery
[erratum appears in Anesth Analg 2006 Mar;
102(3):881]. Anesth Analg 102:298–305, 2006.
94. Erlandsson K, Odenstedt H, Lundin S, Stenqvist O:
Positive end-expiratory pressure optimization using
electric impedance tomography in morbidly obese
patients during laparoscopic gastric bypass surgery.
Acta Anaesthesiol Scand 50:833–839, 2006.
95. Dhonneur G, Combes X, Leroux B, et al: Postope-
rative obstructive apnea. Anesth Analg 89:762–767,
1999.
96. Benumof JL: Obstructive sleep apnea in the adult
obese patient: Implications for airway management.
J Clin Anesth 13:144–156, 2001.
97. Abernethy DR, Greenblatt DJ, Smith TW. Digoxin
disposition in obesity: Clinical pharmacokinetic
investigation. Am Heart J 102:740–744, 1981.
98. Christoff PB, Conti DR, Naylor C, Jusko WJ: Pro-
cainamide disposition in obesity. Drug Intell Clin
Pharm 17:516–522, 1983.
99. Egan TD, Huizinga B, Gupta SK, et al: Remifentanil
pharmacokinetics in obese versus lean patients.
Anesthesiology 89:562–573, 1998.
100. Ogunnaike BO, Jones SB, Jones DB, et al: Anesthetic
considerations for bariatric surgery. Anesth Analg
95:1793–1805, 2002.
101. Juvin P, Vadam C, Malek L, et al: Postoperative reco-
very after desflurane, propofol, or isoflurane anes-
thesiaamongmorbidlyobes
epatients:Aprospectiverandomized study. Anesth Analg 91:714–719,
2000.
102. De Baerdemaeker LEC, Struys MMRF, Jacobs S, et al.
Optimization of desflurane administration in mor-
bidly obese patients: A comparison with sevoflu-
rane using an “inhalation bolus” technique Br
J Anaesth 91:638–650, 2003.
103. De Baerdemaeker LEC, Jacobs S, Den Blauwen
NMM, et al: Postoperative results after desflurane
or sevoflurane combined with remifentanil in
morbidly obese patients. Obes Surg 16:728–733,
2007.
104. Kalinowski CP, Kirsch JR: Strategies for prophylaxis
and treatment for aspiration. Best Pract Res Clin
Anaesthesiol 18:719–737, 2004.
105. Jones KL, Russo A, Stevens JE, et al. Predictors of
delayed gastric emptying in diabetes Diabetes Care
24:1264–1269, 2001.
106. Illing L, Duncan PG, Yip R: Gastroesophageal reflux
during anaesthesia. Can J Anaesth 39:466–470,
1992.
107. Maltby JR, Pytka S, Watson NC, et al: Drinking
300mL of clear fluid two hours before surgery has
no effect on gastric fluid volume and pH in fasting
and non-fasting obese patients. Can J Anaesth
51:111–115, 2004.
108. Hodgkinson R, Husain FJ: Obesity and the cephalad
spread of analgesia following epidural administra-
tion of bupivacaine for cesarean section. Anesth
Analg 59:89–92, 1980.
109. Hodgkinson R, Husain FJ: Obesity, gravity, and
spread of epidural anesthesia. Anesth Analg 60:
421–424, 1981.
110. von Ungern-Sternberg BS, Regli A, Reber A, et al:
Effect of obesity and thoracic epidural analgesia on
perioperative spirometry. Br J Anaesth 94:121–127,
2005.
111. Capella JF, Capella RF: Is routine invasive monito-
ring indicated in surgery for the morbidly obese?
Obes Surg 6:50–53, 1996.
112. Sharma SK, McCauley J, Cottam D, et al: Acute
changes in renal function after laparoscopic gastric
surgery for morbid obesity. Surg Obes Relat Dis
2:389–392, 2006.
113. Ricciardi R, Town RJ, Kellogg TA, et al: Outcomes
after open versus laparoscopic gastric bypass. Surg
Laparosc Endosc Percutan Techn 16:317–320,
2006.
114. Poulose BK, Griffin MR, Moore DE, et al: Risk
factors for post-operative mortality in bariatric
surgery. J Surg Res 127:1–7, 2005.
115. Fernandez AZ Jr, DeMaria EJ, Tichansky DS, et al:
Experience with over 3,000 open and laparoscopic
bariatric procedures: Multivariate analysis of factors
related to leak and resultant mortality. Surg Endosc
18:193–197, 2004.
116. Podnos YD, Jimenez JC, Wilson SE, et al: Complica-
tions after laparoscopic gastric bypass: A review of
3464 cases. Arch Surg 138:957–961, 2003.
117. Derzie AJ, Silvestri F, Liriano E, Benotti P: Wound
closure technique and acute wound complications
in gastric surgery for morbid obesity: A prospective
randomized trial. J Am Coll Surg 191:238–243,
2000.
118. Gonzalez R, Sarr MG, Smith CD, et al: Diagnosis
and contemporary management of anastomotic
leaks after gastric bypass for obesity. J Am Coll Surg
204:47–55, 2007.
119. Hwang RF, Swartz DE, Felix EL: Causes of small
bowel obstruction after laparoscopic gastric bypass.
Surg Endosc 18:1631–1635, 2004.
120. Livingston EH, Arterburn D, Schifftner TL, et al:
National Surgical Quality Improvement Program
analysis of bariatric operations: Modifiable risk
factors contribute to bariatric surgical adverse
outcomes. J Am Coll Surg 203:625–633, 2006.
121. Juhasz-Pocsine K, Rudnicki SA, Archer RL, Harik
SI. Neurologic complications of gastric bypass
surgery for morbid obesity Neurology 68:
1843–1850, 2007.
122. Singh S, Nautiyal A: Neurologic complications of
bariatric surgery. Mayo Clin Proc 80:136–137,
2005.
123. Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG,
et al: A controlled study of peripheral neuropathy
after bariatric surgery. Neurology 63:1462–1470,
2004.
124. Parkes E: Nutritional management of patients after
bariatric surgery. Am J Med Sci 331:207–213, 2006.
125. Poitou Bernert C, Ciangura C, Coupaye M, et al:
Nutritional deficiency after gastric bypass: Diagno-
sis, prevention and treatment. Diabetes Metab 33:
13–24, 2007.
126. Xanthakos SA, Inge TH: Nutritional consequences
of bariatric surgery. Curr Opin Clin Nutr Metab
Care 9:489–496, 2006.
127. DindoD,MullerMK,WeberM,ClavienP-A:Obesity
in general elective surgery. Lancet 361:2032–2035,
2003.
128. Moulton NJ, Cressell LL, Mackey ME, et al: Obesity
is not a risk factor for significant adverse outcomes
after cardiac surgery. Circulation 94(II)87–92,
1996.
129. Shapiro M, Munoz A, Dager IB, et al: Risk factors
for infections at the operative site after abdominal
or vaginal hysterectomy. N Engl J Med 307:
1661–1666, 1982.
130. Brandt M, Harder K, Woallchuck KP, et al: Severe
obesity does not adversely affect perioperative mor-
tality and morbidity in coronary bypass surgery. Eur
J Cardiothorac Surg 19:662–666, 2001.
131. Engleman DT, Adams DH, Byrne JG, et al: Impact
of body mass index and abdomen on morbidity and
mortality of the cardiac surgery. J Thorac Cardio-
vasc Surg 118:866–873, 1999.
1870
Anestesia por subespecialidades en el adulto
IV